Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! for Women with Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20

The Oncotype DX(®) Recurrence Score(®) (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast cancer. Adjuvant! was developed using SEER registry data and results from the Early Breast Cancer Clinical Trialists’ overview analyses to estimate outc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res Treat
Main Authors: Tang, Gong, Shak, Steven, Paik, Soonmyung, Anderson, Stewart J., Costantino, Joseph P., Geyer, Charles E., Mamounas, Eleftherios P., Wickerham, D. Lawrence, Wolmark, Norman
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266581/
https://ncbi.nlm.nih.gov/pubmed/21221771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-1331-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki